Kuros Biosciences AG - Asset Resilience Ratio

Latest as of June 2025: 16.77%

Kuros Biosciences AG (KURN) has an Asset Resilience Ratio of 16.77% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See KURN working capital efficiency to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

CHF18.44 Million

≈ $23.32 Million USD Cash + Short-term Investments

Total Assets

CHF109.97 Million

≈ $139.03 Million USD All company assets

Resilience Assessment

Good

Financial Resilience Level

Asset Resilience Ratio Trend (2005–2023)

This chart shows how Kuros Biosciences AG's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see KURN total asset value.

Liquid Assets Composition Over Time

This chart breaks down Kuros Biosciences AG's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read Kuros Biosciences AG balance sheet liabilities for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CHF18.44 Million	16.77%
Short-term Investments	CHF0.00	0%
Total Liquid Assets	CHF18.44 Million	16.77%

Asset Resilience Insights

Good Liquidity Position: Kuros Biosciences AG maintains a healthy 16.77% of assets in liquid form.
This level provides good financial flexibility while maintaining productive asset deployment.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Kuros Biosciences AG Industry Peers by Asset Resilience Ratio

Compare Kuros Biosciences AG's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
TransMedics Group Inc NASDAQ:TMDX	Medical Devices	0.00%
Jiangsu Yuyue Medical Equipment & Supply Co Ltd SHE:002223	Medical Devices	0.84%
Novocure Ltd NASDAQ:NVCR	Medical Devices	43.72%
Shenzhen New Industries Biomedical SHE:300832	Medical Devices	9.95%
Jafron Biomedical Co Ltd SHE:300529	Medical Devices	34.37%
Hangzhou AGS MedTech Co. Ltd. A SHG:688581	Medical Devices	18.80%
Nanjing Vishee Medical Technology Co Ltd SHG:688580	Medical Devices	10.74%
Nanjing Medlander Medical Technology Co. Ltd. A SHG:688273	Medical Devices	34.29%

Annual Asset Resilience Ratio for Kuros Biosciences AG (2005–2023)

The table below shows the annual Asset Resilience Ratio data for Kuros Biosciences AG.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2023-12-31	0.48%	CHF342.00K ≈ $432.38K	CHF71.46 Million ≈ $90.35 Million	-1.52pp
2015-12-31	1.99%	CHF65.00K ≈ $82.18K	CHF3.26 Million ≈ $4.12 Million	-10.99pp
2011-12-31	12.98%	CHF4.00 Million ≈ $5.06 Million	CHF30.81 Million ≈ $38.96 Million	-1.81pp
2010-12-31	14.80%	CHF8.00 Million ≈ $10.11 Million	CHF54.07 Million ≈ $68.36 Million	-39.06pp
2009-12-31	53.86%	CHF37.00 Million ≈ $46.78 Million	CHF68.70 Million ≈ $86.86 Million	+16.84pp
2008-12-31	37.02%	CHF41.00 Million ≈ $51.84 Million	CHF110.75 Million ≈ $140.02 Million	-16.40pp
2007-12-31	53.42%	CHF66.00 Million ≈ $83.44 Million	CHF123.56 Million ≈ $156.21 Million	+22.06pp
2006-12-31	31.35%	CHF18.00 Million ≈ $22.76 Million	CHF57.41 Million ≈ $72.58 Million	+30.89pp
2005-12-31	0.46%	CHF379.00K ≈ $479.16K	CHF82.39 Million ≈ $104.17 Million	--

pp = percentage points

About Kuros Biosciences AG

SW:KURN Switzerland Medical Devices

Market Cap

$846.66 Million

CHF669.68 Million CHF

Market Cap Rank

#10404 Global

#129 in Switzerland

Share Price

CHF16.88

Change (1 day)

-5.38%

52-Week Range

CHF16.88 - CHF33.36

All Time High

CHF36.96